Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PHARMCONSULT AS
AS
Active
Org 991054162
Terrasseveien 6, 1369
Stabekk
Business and other management consultancy activities
·
NACE 7020
Est. 2007 · 19 years old
5 employees
www.pharmconsult.no
Monitor
Share
Norway
/
Companies
/
Business and other management consultancy activities
/
PHARMCONSULT AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
3M
4M
6M
5M
2021
4M
2022
4M
2023
4M
2024
2M
2025
EBITDA
NOK millions
4M
3M
2M
1M
0M
3M
2021
2M
-33%
2022
1M
-50%
2023
2M
+100%
2024
0M
-100%
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
4 567
4 154
4 097
3 596
1 784
Staff expenses
−968
−962
−964
−1 054
−968
EBITDA
2 636
2 070
1 434
1 635
203
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
2 636
2 070
1 434
1 635
203
Net financials
−10
−22
−4
67
148
Profit before tax
2 626
2 048
1 430
1 702
351
Tax
572
451
328
344
44
Net profit
2 054
1 598
1 102
1 358
307
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
6 719
8 031
8 253
8 331
7 995
Equity
3 382
4 980
5 852
7 210
7 517
Long-term debt
1 945
1 689
983
233
0
Short-term debt
1 391
1 362
1 418
888
478
Total debt
3 336
3 051
2 401
1 121
478
Financial ratios
5-year trend
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
2021
2025
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
2021
2025
Return on equity
4.1%
This company
18.4%
Market median
-78% vs market
2021
2025
Net profit margin
17.2%
This company
8.1%
Market median
+112% vs market
2021
2025
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
2021
2025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on PHARMCONSULT AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
